Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:39 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2 / Phase 3CompletedINTERVENTIONAL

Vasopressin in Traumatic Hemorrhagic Shock Study

ClinicalTrials.gov · NCT00379522 · Registry updated: 2014-11-05

Condition / research focus: Shock; Hypovolemia; Hemorrhagic Shock
Sponsor: Volker Wenzel
Countries with listed sites: Austria · Germany
Registry dates and results: Start: 2010-07. Completion: 2014-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Pressyn, CPREssin, Pitressin
Saline placebo (drug) — also listed as: Kochsalz, Saline

Where the study takes place — 14 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

HEMS Ybbsitz / Hospital Amstetten
Amstetten, Lower Austria, Austria
Site recruitment: Not reported
Hospital Krems
Krems, Lower Austria, Austria
Site recruitment: Not reported
Hospital Wiener Neustadt
Wiener Neustadt, Lower Austria, Austria
Site recruitment: Not reported
Hospital Salzburg
Salzburg, State of Salzburg, Austria
Site recruitment: Not reported
Medical University of Graz
Graz, Styria, Austria
Site recruitment: Not reported
Medical University of Innsbruck
Innsbruck, Tyrol, Austria
Site recruitment: Not reported
Hospital Linz
Linz, Upper Austria, Austria
Site recruitment: Not reported
HEMS Suben / Landeskrankenhaus Schärding
Schaerding, Upper Austria, Austria
Site recruitment: Not reported
University Hospital of Dresden
Dresden, Germany
Site recruitment: Not reported
University Hospital of Goettingen
Göttingen, Germany
Site recruitment: Not reported
University Hospital of Mannheim
Mannheim, Germany
Site recruitment: Not reported
BG-Unfallklinik Murnau
Murnau am Staffelsee, Germany
Site recruitment: Not reported
Ev. Jung-Stilling-Krankenhaus
Siegen, Germany
Site recruitment: Not reported
Bundeswehrkrankenhaus Ulm
Ulm, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3TerminatedINTERVENTIONAL

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

ClinicalTrials.gov · NCT00742339 · Registry updated: 2014-10-15

Condition / research focus: Cirrhosis; Hepatorenal Syndrome
Sponsor: University of Padova
Countries with listed sites: Italy
Registry dates and results: Start: 2005-05. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin plus albumin (drug)
Midodrine plus octreotide plus human albumin (drug)

Where the study takes place — 1 listed sites

Dept. of Clinical and Experimental Medicine, University of Padova
Padova, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)

ClinicalTrials.gov · NCT01638663 · Registry updated: 2014-10-09

Condition / research focus: Cardiovascular Diseases; Nephropathy
Sponsor: Regional Hospital Holstebro
Countries with listed sites: Denmark
Registry dates and results: Start: 2012-05. Completion: 2014-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: Samsca
Placebo (drug) — also listed as: Unikalk

Where the study takes place — 1 listed sites

Safa Therwani
Holstebro, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

ClinicalTrials.gov · NCT00961532 · Registry updated: 2014-08-28

Condition / research focus: Intracerebral Hemorrhage
Sponsor: Northwestern University
Countries with listed sites: United States
Registry dates and results: Start: 2010-12. Completion: 2013-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DDAVP injection (desmopressin acetate) (drug)

Where the study takes place — 1 listed sites

Northwestern Memorial Hospital
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

ClinicalTrials.gov · NCT00380575 · Registry updated: 2014-05-02

Condition / research focus: Hyponatremia
Sponsor: Cumberland Pharmaceuticals
Countries with listed sites: Canada · Israel · South Africa · United States
Registry dates and results: Start: 2000-08. Completion: 2003-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

YM087 (drug)

Where the study takes place — 47 listed sites

Facility not reported
Mobile, Alabama, United States
Site recruitment: Not reported
Facility not reported
Phoenix, Arizona, United States
Site recruitment: Not reported
Facility not reported
Tuscon, Arizona, United States
Site recruitment: Not reported
Facility not reported
La Jolla, California, United States
Site recruitment: Not reported
Facility not reported
Los Angeles, California, United States
Site recruitment: Not reported
Facility not reported
Santa Rosa, California, United States
Site recruitment: Not reported
Facility not reported
Miami, Florida, United States
Site recruitment: Not reported
Facility not reported
Plantation, Florida, United States
Site recruitment: Not reported
Facility not reported
Springfield, Illinois, United States
Site recruitment: Not reported
Facility not reported
Indianapolis, Indiana, United States
Site recruitment: Not reported
Facility not reported
Shreveport, Louisiana, United States
Site recruitment: Not reported
Facility not reported
Worchester, Massachusetts, United States
Site recruitment: Not reported
Facility not reported
Petoskey, Michigan, United States
Site recruitment: Not reported
Facility not reported
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Facility not reported
Rolla, Missouri, United States
Site recruitment: Not reported
Facility not reported
St Louis, Missouri, United States
Site recruitment: Not reported
Facility not reported
Omaha, Nebraska, United States
Site recruitment: Not reported
Facility not reported
New York, New York, United States
Site recruitment: Not reported
Facility not reported
Cleveland, Ohio, United States
Site recruitment: Not reported
Facility not reported
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Facility not reported
Columbia, South Carolina, United States
Site recruitment: Not reported
Facility not reported
Sioux Falls, South Dakota, United States
Site recruitment: Not reported
Facility not reported
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Facility not reported
Norfolk, Virginia, United States
Site recruitment: Not reported
Facility not reported
Salem, Virginia, United States
Site recruitment: Not reported
Facility not reported
Huntington, West Virginia, United States
Site recruitment: Not reported
Facility not reported
Madison, Wisconsin, United States
Site recruitment: Not reported
Facility not reported
Drummondville, Quebec, Canada
Site recruitment: Not reported
Facility not reported
Montreal 2 Sites, Quebec, Canada
Site recruitment: Not reported
Facility not reported
Ashkelon, Israel
Site recruitment: Not reported
Facility not reported
Beersheba, Israel
Site recruitment: Not reported
Facility not reported
Haifa 2 Sites, Israel
Site recruitment: Not reported
Facility not reported
Holon, Israel
Site recruitment: Not reported
Facility not reported
Jerusalem, Israel
Site recruitment: Not reported
Facility not reported
Rehovot, Israel
Site recruitment: Not reported
Facility not reported
Safed, Israel
Site recruitment: Not reported
Facility not reported
Tel Aviv, Israel
Site recruitment: Not reported
Facility not reported
Tel HaShomer, Israel
Site recruitment: Not reported
Facility not reported
Bloemfontein, South Africa
Site recruitment: Not reported
Facility not reported
Buff, South Africa
Site recruitment: Not reported
Facility not reported
Durban, South Africa
Site recruitment: Not reported
Facility not reported
East London, South Africa
Site recruitment: Not reported
Facility not reported
eManzimtoti, South Africa
Site recruitment: Not reported
Facility not reported
Johannesburg, South Africa
Site recruitment: Not reported
Facility not reported
Lyttelton Manor, South Africa
Site recruitment: Not reported
Facility not reported
Port Elizabeth, South Africa
Site recruitment: Not reported
Facility not reported
Pretoria, South Africa
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery

ClinicalTrials.gov · NCT02084342 · Registry updated: 2014-03-11

Condition / research focus: Idiopathic Scoliosis
Sponsor: Liu Weifeng
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-12. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

tranexamic acid and sodium chloride injection (drug) — also listed as: TXA
normal saline (drug) — also listed as: NS
desmopressin acetate injection (drug) — also listed as: DDAVP

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension

ClinicalTrials.gov · NCT01271114 · Registry updated: 2014-03-10

Condition / research focus: Septic Shock; Sepsis-associated Hypotension
Sponsor: Hospital General de Ciudad Real
Countries with listed sites: Spain
Registry dates and results: Start: 2012-06. Completion: 2013-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hypertonic Saline and Terlipressin (drug)
Normal saline and norepinephrine (drug)

Where the study takes place — 1 listed sites

Hospital General de Ciudad Real
Ciudad Real, Ciudad Real, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Hemodynamic Effects of Vasopressin in Early Septic Shock Stage

ClinicalTrials.gov · NCT02053675 · Registry updated: 2014-02-04

Condition / research focus: Septic Shock
Sponsor: Federal University of São Paulo
Countries with listed sites: Brazil
Registry dates and results: Start: 2008-05. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin infusion (drug)

Where the study takes place — 1 listed sites

Hospital São Paulo
São Paulo, São Paulo/SP, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

ClinicalTrials.gov · NCT00462670 · Registry updated: 2014-02-04

Condition / research focus: Edema, Cardiac
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2007-04. Completion: 2008-10 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OPC-41061(Tolvaptan) (drug)

Where the study takes place — 8 listed sites

Facility not reported
Chubu Region, Japan
Site recruitment: Not reported
Facility not reported
Chugoku Region, Japan
Site recruitment: Not reported
Facility not reported
Hokkaido Region, Japan
Site recruitment: Not reported
Facility not reported
Kanto Region, Japan
Site recruitment: Not reported
Facility not reported
Kinki Region, Japan
Site recruitment: Not reported
Facility not reported
Kyushu Region, Japan
Site recruitment: Not reported
Facility not reported
Shikoku Region, Japan
Site recruitment: Not reported
Facility not reported
Tohoku Region, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

ClinicalTrials.gov · NCT00544869 · Registry updated: 2014-01-30

Condition / research focus: Cardiac Edema
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2007-10. Completion: 2009-02 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OPC-41061 （Tolvaptan) (drug)

Where the study takes place — 6 listed sites

Facility not reported
Chubu Region, Japan
Site recruitment: Not reported
Facility not reported
Hokkaido Region, Japan
Site recruitment: Not reported
Facility not reported
Kanto Region, Japan
Site recruitment: Not reported
Facility not reported
Kinki Region, Japan
Site recruitment: Not reported
Facility not reported
Kyuush, Japan
Site recruitment: Not reported
Facility not reported
Shikoku Region, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants

ClinicalTrials.gov · NCT00850720 · Registry updated: 2014-01-07

Condition / research focus: Congenital Heart Disease
Sponsor: Emory University
Countries with listed sites: United States
Registry dates and results: Start: 2009-03. Completion: 2009-10 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood draws (other) — also listed as: Tests being analyzed:, • Cortisol, • Vasopressin (ADH), • Cortisol Free, • Thyroid Stimulating Hormone (TSH), • Free Thyroxine(FT4)

Where the study takes place — 1 listed sites

Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

ClinicalTrials.gov · NCT00525265 · Registry updated: 2013-12-25

Condition / research focus: Cardiac Edema
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2007-09. Completion: 2009-01 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OPC-41061(Tolvaptan) (drug)
Placebo (drug)

Where the study takes place — 2 listed sites

Facility not reported
Kanto Region, Japan
Site recruitment: Not reported
Facility not reported
Kyushu Region, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction

ClinicalTrials.gov · NCT01382134 · Registry updated: 2013-11-15

Condition / research focus: Platelet Dysfunction; Hemodilution; Mild Hypothermia; NSAID; Desmopressin
Sponsor: The University of Hong Kong
Countries with listed sites: China
Registry dates and results: Start: 2011-07. Completion: 2013-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Aspirin, desmopressin (drug)
Placebo, desmopressin (drug)

Where the study takes place — 1 listed sites

Queen Mary Hospital
Hong Kong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis

ClinicalTrials.gov · NCT01932151 · Registry updated: 2013-09-05

Condition / research focus: Hepatorenal Syndrome
Sponsor: Hospital Clinic of Barcelona
Countries with listed sites: Spain
Registry dates and results: Start: 2012-12. Completion: 2013-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin and albumin (drug) — also listed as: - Glypressyn, Ferring SA, Saint-Prex, Switzerland., - Albúmina Humana Grífols, Grífols , Barcelona, Spain.

Where the study takes place — 1 listed sites

Hospital Clinic de Barcelona
Barcelona, Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

ClinicalTrials.gov · NCT01228682 · Registry updated: 2013-05-01

Condition / research focus: SIADH; Non-SIADH Hyponatremia; Non-Hyponatremia
Sponsor: Otsuka Frankfurt Research Institute GmbH
Countries with listed sites: Denmark · Germany · Italy · Norway · Spain · Sweden · United Kingdom
Registry dates and results: Start: 2010-10. Completion: 2014-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: Samsca

Where the study takes place — 47 listed sites

Otsuka Study location 45-001
Copenhagen, Denmark
Site recruitment: Not reported
Otsuka Study location 45-006
Holstebro, Denmark
Site recruitment: Not reported
Otsuka Study location 49.007
Aachen, Germany
Site recruitment: Not reported
Otsuka Study location 49.004
Cologne, Germany
Site recruitment: Not reported
Otsuka Study location 49.016
Dresden, Germany
Site recruitment: Not reported
Otsuka Study location 49.011
Düsseldorf, Germany
Site recruitment: Not reported
Otsuka Study location 49.002
Hamburg, Germany
Site recruitment: Not reported
Otsuka Study location 49.012
Hanover, Germany
Site recruitment: Not reported
Otsuka Study location 49.018
Hanover, Germany
Site recruitment: Not reported
Otsuka Study Location 49-020
Heidelberg, Germany
Site recruitment: Not reported
Otsuka Study location 49-024
Heidelberg, Germany
Site recruitment: Not reported
Otsuka Study location 49.009
Lübeck, Germany
Site recruitment: Not reported
Otsuka Study location 49.017
Mannheim, Germany
Site recruitment: Not reported
Otsuka Study location 49-019
Regensberg, Germany
Site recruitment: Not reported
Otsuka Study location 49-021
Rostock, Germany
Site recruitment: Not reported
Otsuka study location 49-001
Würzburg, Germany
Site recruitment: Not reported
Otsuka Study location 39-001
Cuneo, Italy
Site recruitment: Not reported
Otsuka Study location 39.007
Florence, Italy
Site recruitment: Not reported
Otsuka Study location 39.005
Siena, Italy
Site recruitment: Not reported
Otsuka Study location 47-001
Lorenskog, Norway
Site recruitment: Not reported
Otsuka Study location 34-007
Alicante, Spain
Site recruitment: Not reported
Otsuka Study location 34-014
Castellon, Spain
Site recruitment: Not reported
Otsuka Study location 34-015
Castellon, Spain
Site recruitment: Not reported
Otsuka Study location 34-013
Córdoba, Spain
Site recruitment: Not reported
Otsuka Study location 34-005
Madrid, Spain
Site recruitment: Not reported
Otsuka Study location 34.017
Majadahonda, Spain
Site recruitment: Not reported
Otsuka Study location 34-002
Seville, Spain
Site recruitment: Not reported
Otsuka Study location 34-012
Seville, Spain
Site recruitment: Not reported
Otsuka Study Location 46.001
Gothenburg, Sweden
Site recruitment: Not reported
Otsuka Study location 46-004
Karlstad, Sweden
Site recruitment: Not reported
Otsuka Study location 46.002
Linköping, Sweden
Site recruitment: Not reported
Otsuka Study location 46-003
Stockholm, Sweden
Site recruitment: Not reported
Otsuka Study location 44.024
Birmingham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.019
Coventry, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.003
Durham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-023
Hartlepool, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.005
Kingston, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.006
Liverpool, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.016
Liverpool, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-001
Manchester, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.007
Manchester, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.013
Manchester, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.021
Nuneaton, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-027
Oldham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.015
Oldham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-025
Preston, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.004
Southampton, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery

ClinicalTrials.gov · NCT01505231 · Registry updated: 2013-02-12

Condition / research focus: Shock
Sponsor: University of Sao Paulo
Countries with listed sites: Brazil
Registry dates and results: Start: 2012-01. Completion: 2013-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Instituto do Coração
São Paulo, São Paulo, Brazil
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

ClinicalTrials.gov · NCT01700478 · Registry updated: 2013-02-11

Condition / research focus: Hemorrhage
Sponsor: University Hospital of the West Indies
Countries with listed sites: Jamaica
Registry dates and results: Start: 2005-02. Completion: 2005-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol + vasopressin (drug) — also listed as: Cytotec
Vasopressin (drug) — also listed as: Anti-diuretic hormone

Where the study takes place — 1 listed sites

University Hospital of the West Indies
Kingston, Jamaica
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin

ClinicalTrials.gov · NCT00635310 · Registry updated: 2012-12-20

Condition / research focus: Chronic Hepatitis C; Chronic Hepatitis B; Biopsy; Hemodialysis
Sponsor: National Taiwan University Hospital
Countries with listed sites: Taiwan
Registry dates and results: Start: 2005-01. Completion: 2013-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Percutaneous liver biopsy (procedure)
Percutaneous liver biopsy (procedure)

Where the study takes place — 5 listed sites

Chiayi Christian Hospital
Chiayi City, Taiwan
Site recruitment: Recruiting
St. Martin De Porres Hospital
Chiayi City, Taiwan
Site recruitment: Recruiting
National Taiwan University Hospital, Yun-Lin Branch
Douliu, Taiwan
Site recruitment: Recruiting
Far Eastern Memorial Hospital
Taipei, Taiwan
Site recruitment: Recruiting
National Taiwan University Hospital
Taipei, Taiwan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

ClinicalTrials.gov · NCT01742689 · Registry updated: 2012-12-05

Condition / research focus: Renal Colic; Pain
Sponsor: Tehran University of Medical Sciences
Countries with listed sites: Iran
Registry dates and results: Start: 2012-03. Completion: 2013-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin intranasal spray (drug) — also listed as: DDAVP, DesmoMelt, Stimate, Minirin,Desmex
Placebo intranasal spray (drug)
Indomethacin suppository (drug) — also listed as: Indocin, Indocid, Indochron, INDOMET

Where the study takes place — 2 listed sites

Imam Khomeini General Hospital
Tehran, Tehran Province, Iran
Site recruitment: Recruiting
Shariati Hospital
Tehran, Tehran Province, Iran
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites

ClinicalTrials.gov · NCT01716611 · Registry updated: 2012-10-30

Condition / research focus: Hyponatremia; Ascites
Sponsor: Konkuk University Medical Center
Countries with listed sites: South Korea
Registry dates and results: Start: 2012-11. Completion: 2014-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: SAMSCA
placebo (drug)

Where the study takes place — 1 listed sites

Konkuk University Medical Center
Seoul, Seoul, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:39 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2 / Phase 3CompletedINTERVENTIONAL

Vasopressin in Traumatic Hemorrhagic Shock Study

ClinicalTrials.gov · NCT00379522 · Registry updated: 2014-11-05

Condition / research focus: Shock; Hypovolemia; Hemorrhagic Shock
Sponsor: Volker Wenzel
Countries with listed sites: Austria · Germany
Registry dates and results: Start: 2010-07. Completion: 2014-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug) — also listed as: Pressyn, CPREssin, Pitressin
Saline placebo (drug) — also listed as: Kochsalz, Saline

Where the study takes place — 14 listed sites

HEMS Ybbsitz / Hospital Amstetten
Amstetten, Lower Austria, Austria
Site recruitment: Not reported
Hospital Krems
Krems, Lower Austria, Austria
Site recruitment: Not reported
Hospital Wiener Neustadt
Wiener Neustadt, Lower Austria, Austria
Site recruitment: Not reported
Hospital Salzburg
Salzburg, State of Salzburg, Austria
Site recruitment: Not reported
Medical University of Graz
Graz, Styria, Austria
Site recruitment: Not reported
Medical University of Innsbruck
Innsbruck, Tyrol, Austria
Site recruitment: Not reported
Hospital Linz
Linz, Upper Austria, Austria
Site recruitment: Not reported
HEMS Suben / Landeskrankenhaus Schärding
Schaerding, Upper Austria, Austria
Site recruitment: Not reported
University Hospital of Dresden
Dresden, Germany
Site recruitment: Not reported
University Hospital of Goettingen
Göttingen, Germany
Site recruitment: Not reported
University Hospital of Mannheim
Mannheim, Germany
Site recruitment: Not reported
BG-Unfallklinik Murnau
Murnau am Staffelsee, Germany
Site recruitment: Not reported
Ev. Jung-Stilling-Krankenhaus
Siegen, Germany
Site recruitment: Not reported
Bundeswehrkrankenhaus Ulm
Ulm, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3TerminatedINTERVENTIONAL

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

ClinicalTrials.gov · NCT00742339 · Registry updated: 2014-10-15

Condition / research focus: Cirrhosis; Hepatorenal Syndrome
Sponsor: University of Padova
Countries with listed sites: Italy
Registry dates and results: Start: 2005-05. Completion: 2013-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin plus albumin (drug)
Midodrine plus octreotide plus human albumin (drug)

Where the study takes place — 1 listed sites

Dept. of Clinical and Experimental Medicine, University of Padova
Padova, Italy
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)

ClinicalTrials.gov · NCT01638663 · Registry updated: 2014-10-09

Condition / research focus: Cardiovascular Diseases; Nephropathy
Sponsor: Regional Hospital Holstebro
Countries with listed sites: Denmark
Registry dates and results: Start: 2012-05. Completion: 2014-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: Samsca
Placebo (drug) — also listed as: Unikalk

Where the study takes place — 1 listed sites

Safa Therwani
Holstebro, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

ClinicalTrials.gov · NCT00961532 · Registry updated: 2014-08-28

Condition / research focus: Intracerebral Hemorrhage
Sponsor: Northwestern University
Countries with listed sites: United States
Registry dates and results: Start: 2010-12. Completion: 2013-12 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DDAVP injection (desmopressin acetate) (drug)

Where the study takes place — 1 listed sites

Northwestern Memorial Hospital
Chicago, Illinois, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia

ClinicalTrials.gov · NCT00380575 · Registry updated: 2014-05-02

Condition / research focus: Hyponatremia
Sponsor: Cumberland Pharmaceuticals
Countries with listed sites: Canada · Israel · South Africa · United States
Registry dates and results: Start: 2000-08. Completion: 2003-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

YM087 (drug)

Where the study takes place — 47 listed sites

Facility not reported
Mobile, Alabama, United States
Site recruitment: Not reported
Facility not reported
Phoenix, Arizona, United States
Site recruitment: Not reported
Facility not reported
Tuscon, Arizona, United States
Site recruitment: Not reported
Facility not reported
La Jolla, California, United States
Site recruitment: Not reported
Facility not reported
Los Angeles, California, United States
Site recruitment: Not reported
Facility not reported
Santa Rosa, California, United States
Site recruitment: Not reported
Facility not reported
Miami, Florida, United States
Site recruitment: Not reported
Facility not reported
Plantation, Florida, United States
Site recruitment: Not reported
Facility not reported
Springfield, Illinois, United States
Site recruitment: Not reported
Facility not reported
Indianapolis, Indiana, United States
Site recruitment: Not reported
Facility not reported
Shreveport, Louisiana, United States
Site recruitment: Not reported
Facility not reported
Worchester, Massachusetts, United States
Site recruitment: Not reported
Facility not reported
Petoskey, Michigan, United States
Site recruitment: Not reported
Facility not reported
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Facility not reported
Rolla, Missouri, United States
Site recruitment: Not reported
Facility not reported
St Louis, Missouri, United States
Site recruitment: Not reported
Facility not reported
Omaha, Nebraska, United States
Site recruitment: Not reported
Facility not reported
New York, New York, United States
Site recruitment: Not reported
Facility not reported
Cleveland, Ohio, United States
Site recruitment: Not reported
Facility not reported
Oklahoma City, Oklahoma, United States
Site recruitment: Not reported
Facility not reported
Columbia, South Carolina, United States
Site recruitment: Not reported
Facility not reported
Sioux Falls, South Dakota, United States
Site recruitment: Not reported
Facility not reported
Chattanooga, Tennessee, United States
Site recruitment: Not reported
Facility not reported
Norfolk, Virginia, United States
Site recruitment: Not reported
Facility not reported
Salem, Virginia, United States
Site recruitment: Not reported
Facility not reported
Huntington, West Virginia, United States
Site recruitment: Not reported
Facility not reported
Madison, Wisconsin, United States
Site recruitment: Not reported
Facility not reported
Drummondville, Quebec, Canada
Site recruitment: Not reported
Facility not reported
Montreal 2 Sites, Quebec, Canada
Site recruitment: Not reported
Facility not reported
Ashkelon, Israel
Site recruitment: Not reported
Facility not reported
Beersheba, Israel
Site recruitment: Not reported
Facility not reported
Haifa 2 Sites, Israel
Site recruitment: Not reported
Facility not reported
Holon, Israel
Site recruitment: Not reported
Facility not reported
Jerusalem, Israel
Site recruitment: Not reported
Facility not reported
Rehovot, Israel
Site recruitment: Not reported
Facility not reported
Safed, Israel
Site recruitment: Not reported
Facility not reported
Tel Aviv, Israel
Site recruitment: Not reported
Facility not reported
Tel HaShomer, Israel
Site recruitment: Not reported
Facility not reported
Bloemfontein, South Africa
Site recruitment: Not reported
Facility not reported
Buff, South Africa
Site recruitment: Not reported
Facility not reported
Durban, South Africa
Site recruitment: Not reported
Facility not reported
East London, South Africa
Site recruitment: Not reported
Facility not reported
eManzimtoti, South Africa
Site recruitment: Not reported
Facility not reported
Johannesburg, South Africa
Site recruitment: Not reported
Facility not reported
Lyttelton Manor, South Africa
Site recruitment: Not reported
Facility not reported
Port Elizabeth, South Africa
Site recruitment: Not reported
Facility not reported
Pretoria, South Africa
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery

ClinicalTrials.gov · NCT02084342 · Registry updated: 2014-03-11

Condition / research focus: Idiopathic Scoliosis
Sponsor: Liu Weifeng
Countries with listed sites: No country reported
Registry dates and results: Start: 2013-12. Completion: 2014-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

tranexamic acid and sodium chloride injection (drug) — also listed as: TXA
normal saline (drug) — also listed as: NS
desmopressin acetate injection (drug) — also listed as: DDAVP

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension

ClinicalTrials.gov · NCT01271114 · Registry updated: 2014-03-10

Condition / research focus: Septic Shock; Sepsis-associated Hypotension
Sponsor: Hospital General de Ciudad Real
Countries with listed sites: Spain
Registry dates and results: Start: 2012-06. Completion: 2013-12 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Hypertonic Saline and Terlipressin (drug)
Normal saline and norepinephrine (drug)

Where the study takes place — 1 listed sites

Hospital General de Ciudad Real
Ciudad Real, Ciudad Real, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Hemodynamic Effects of Vasopressin in Early Septic Shock Stage

ClinicalTrials.gov · NCT02053675 · Registry updated: 2014-02-04

Condition / research focus: Septic Shock
Sponsor: Federal University of São Paulo
Countries with listed sites: Brazil
Registry dates and results: Start: 2008-05. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin infusion (drug)

Where the study takes place — 1 listed sites

Hospital São Paulo
São Paulo, São Paulo/SP, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Double-blind, Placebo-controlled Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

ClinicalTrials.gov · NCT00462670 · Registry updated: 2014-02-04

Condition / research focus: Edema, Cardiac
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2007-04. Completion: 2008-10 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OPC-41061(Tolvaptan) (drug)

Where the study takes place — 8 listed sites

Facility not reported
Chubu Region, Japan
Site recruitment: Not reported
Facility not reported
Chugoku Region, Japan
Site recruitment: Not reported
Facility not reported
Hokkaido Region, Japan
Site recruitment: Not reported
Facility not reported
Kanto Region, Japan
Site recruitment: Not reported
Facility not reported
Kinki Region, Japan
Site recruitment: Not reported
Facility not reported
Kyushu Region, Japan
Site recruitment: Not reported
Facility not reported
Shikoku Region, Japan
Site recruitment: Not reported
Facility not reported
Tohoku Region, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)

ClinicalTrials.gov · NCT00544869 · Registry updated: 2014-01-30

Condition / research focus: Cardiac Edema
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2007-10. Completion: 2009-02 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OPC-41061 （Tolvaptan) (drug)

Where the study takes place — 6 listed sites

Facility not reported
Chubu Region, Japan
Site recruitment: Not reported
Facility not reported
Hokkaido Region, Japan
Site recruitment: Not reported
Facility not reported
Kanto Region, Japan
Site recruitment: Not reported
Facility not reported
Kinki Region, Japan
Site recruitment: Not reported
Facility not reported
Kyuush, Japan
Site recruitment: Not reported
Facility not reported
Shikoku Region, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableTerminatedOBSERVATIONAL

Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants

ClinicalTrials.gov · NCT00850720 · Registry updated: 2014-01-07

Condition / research focus: Congenital Heart Disease
Sponsor: Emory University
Countries with listed sites: United States
Registry dates and results: Start: 2009-03. Completion: 2009-10 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood draws (other) — also listed as: Tests being analyzed:, • Cortisol, • Vasopressin (ADH), • Cortisol Free, • Thyroid Stimulating Hormone (TSH), • Free Thyroxine(FT4)

Where the study takes place — 1 listed sites

Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

A Clinical Pharmacological Study of OPC-41061 in the Treatment of Cardiac Edema (Congestive Heart Failure)

ClinicalTrials.gov · NCT00525265 · Registry updated: 2013-12-25

Condition / research focus: Cardiac Edema
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Countries with listed sites: Japan
Registry dates and results: Start: 2007-09. Completion: 2009-01 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OPC-41061(Tolvaptan) (drug)
Placebo (drug)

Where the study takes place — 2 listed sites

Facility not reported
Kanto Region, Japan
Site recruitment: Not reported
Facility not reported
Kyushu Region, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of Aspirin, Hemodilution and Desmopressin on Platelet Dysfunction

ClinicalTrials.gov · NCT01382134 · Registry updated: 2013-11-15

Condition / research focus: Platelet Dysfunction; Hemodilution; Mild Hypothermia; NSAID; Desmopressin
Sponsor: The University of Hong Kong
Countries with listed sites: China
Registry dates and results: Start: 2011-07. Completion: 2013-09 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Aspirin, desmopressin (drug)
Placebo, desmopressin (drug)

Where the study takes place — 1 listed sites

Queen Mary Hospital
Hong Kong, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Treatment of Type-1 Hepatorenal Syndrome Associated With Sepsis

ClinicalTrials.gov · NCT01932151 · Registry updated: 2013-09-05

Condition / research focus: Hepatorenal Syndrome
Sponsor: Hospital Clinic of Barcelona
Countries with listed sites: Spain
Registry dates and results: Start: 2012-12. Completion: 2013-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Terlipressin and albumin (drug) — also listed as: - Glypressyn, Ferring SA, Saint-Prex, Switzerland., - Albúmina Humana Grífols, Grífols , Barcelona, Spain.

Where the study takes place — 1 listed sites

Hospital Clinic de Barcelona
Barcelona, Barcelona, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableUnknownOBSERVATIONAL

Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice

ClinicalTrials.gov · NCT01228682 · Registry updated: 2013-05-01

Condition / research focus: SIADH; Non-SIADH Hyponatremia; Non-Hyponatremia
Sponsor: Otsuka Frankfurt Research Institute GmbH
Countries with listed sites: Denmark · Germany · Italy · Norway · Spain · Sweden · United Kingdom
Registry dates and results: Start: 2010-10. Completion: 2014-04 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: Samsca

Where the study takes place — 47 listed sites

Otsuka Study location 45-001
Copenhagen, Denmark
Site recruitment: Not reported
Otsuka Study location 45-006
Holstebro, Denmark
Site recruitment: Not reported
Otsuka Study location 49.007
Aachen, Germany
Site recruitment: Not reported
Otsuka Study location 49.004
Cologne, Germany
Site recruitment: Not reported
Otsuka Study location 49.016
Dresden, Germany
Site recruitment: Not reported
Otsuka Study location 49.011
Düsseldorf, Germany
Site recruitment: Not reported
Otsuka Study location 49.002
Hamburg, Germany
Site recruitment: Not reported
Otsuka Study location 49.012
Hanover, Germany
Site recruitment: Not reported
Otsuka Study location 49.018
Hanover, Germany
Site recruitment: Not reported
Otsuka Study Location 49-020
Heidelberg, Germany
Site recruitment: Not reported
Otsuka Study location 49-024
Heidelberg, Germany
Site recruitment: Not reported
Otsuka Study location 49.009
Lübeck, Germany
Site recruitment: Not reported
Otsuka Study location 49.017
Mannheim, Germany
Site recruitment: Not reported
Otsuka Study location 49-019
Regensberg, Germany
Site recruitment: Not reported
Otsuka Study location 49-021
Rostock, Germany
Site recruitment: Not reported
Otsuka study location 49-001
Würzburg, Germany
Site recruitment: Not reported
Otsuka Study location 39-001
Cuneo, Italy
Site recruitment: Not reported
Otsuka Study location 39.007
Florence, Italy
Site recruitment: Not reported
Otsuka Study location 39.005
Siena, Italy
Site recruitment: Not reported
Otsuka Study location 47-001
Lorenskog, Norway
Site recruitment: Not reported
Otsuka Study location 34-007
Alicante, Spain
Site recruitment: Not reported
Otsuka Study location 34-014
Castellon, Spain
Site recruitment: Not reported
Otsuka Study location 34-015
Castellon, Spain
Site recruitment: Not reported
Otsuka Study location 34-013
Córdoba, Spain
Site recruitment: Not reported
Otsuka Study location 34-005
Madrid, Spain
Site recruitment: Not reported
Otsuka Study location 34.017
Majadahonda, Spain
Site recruitment: Not reported
Otsuka Study location 34-002
Seville, Spain
Site recruitment: Not reported
Otsuka Study location 34-012
Seville, Spain
Site recruitment: Not reported
Otsuka Study Location 46.001
Gothenburg, Sweden
Site recruitment: Not reported
Otsuka Study location 46-004
Karlstad, Sweden
Site recruitment: Not reported
Otsuka Study location 46.002
Linköping, Sweden
Site recruitment: Not reported
Otsuka Study location 46-003
Stockholm, Sweden
Site recruitment: Not reported
Otsuka Study location 44.024
Birmingham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.019
Coventry, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.003
Durham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-023
Hartlepool, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.005
Kingston, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.006
Liverpool, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.016
Liverpool, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-001
Manchester, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.007
Manchester, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.013
Manchester, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.021
Nuneaton, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-027
Oldham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.015
Oldham, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44-025
Preston, United Kingdom
Site recruitment: Not reported
Otsuka Study location 44.004
Southampton, United Kingdom
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Vasopressin Versus Norepinephrine for the Management of Shock After Cardiac Surgery

ClinicalTrials.gov · NCT01505231 · Registry updated: 2013-02-12

Condition / research focus: Shock
Sponsor: University of Sao Paulo
Countries with listed sites: Brazil
Registry dates and results: Start: 2012-01. Completion: 2013-05 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vasopressin (drug)
Norepinephrine (drug)

Where the study takes place — 1 listed sites

Instituto do Coração
São Paulo, São Paulo, Brazil
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

ClinicalTrials.gov · NCT01700478 · Registry updated: 2013-02-11

Condition / research focus: Hemorrhage
Sponsor: University Hospital of the West Indies
Countries with listed sites: Jamaica
Registry dates and results: Start: 2005-02. Completion: 2005-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol + vasopressin (drug) — also listed as: Cytotec
Vasopressin (drug) — also listed as: Anti-diuretic hormone

Where the study takes place — 1 listed sites

University Hospital of the West Indies
Kingston, Jamaica
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableUnknownINTERVENTIONAL

Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin

ClinicalTrials.gov · NCT00635310 · Registry updated: 2012-12-20

Condition / research focus: Chronic Hepatitis C; Chronic Hepatitis B; Biopsy; Hemodialysis
Sponsor: National Taiwan University Hospital
Countries with listed sites: Taiwan
Registry dates and results: Start: 2005-01. Completion: 2013-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Percutaneous liver biopsy (procedure)
Percutaneous liver biopsy (procedure)

Where the study takes place — 5 listed sites

Chiayi Christian Hospital
Chiayi City, Taiwan
Site recruitment: Recruiting
St. Martin De Porres Hospital
Chiayi City, Taiwan
Site recruitment: Recruiting
National Taiwan University Hospital, Yun-Lin Branch
Douliu, Taiwan
Site recruitment: Recruiting
Far Eastern Memorial Hospital
Taipei, Taiwan
Site recruitment: Recruiting
National Taiwan University Hospital
Taipei, Taiwan
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

ClinicalTrials.gov · NCT01742689 · Registry updated: 2012-12-05

Condition / research focus: Renal Colic; Pain
Sponsor: Tehran University of Medical Sciences
Countries with listed sites: Iran
Registry dates and results: Start: 2012-03. Completion: 2013-03 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Desmopressin intranasal spray (drug) — also listed as: DDAVP, DesmoMelt, Stimate, Minirin,Desmex
Placebo intranasal spray (drug)
Indomethacin suppository (drug) — also listed as: Indocin, Indocid, Indochron, INDOMET

Where the study takes place — 2 listed sites

Imam Khomeini General Hospital
Tehran, Tehran Province, Iran
Site recruitment: Recruiting
Shariati Hospital
Tehran, Tehran Province, Iran
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4UnknownINTERVENTIONAL

Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites

ClinicalTrials.gov · NCT01716611 · Registry updated: 2012-10-30

Condition / research focus: Hyponatremia; Ascites
Sponsor: Konkuk University Medical Center
Countries with listed sites: South Korea
Registry dates and results: Start: 2012-11. Completion: 2014-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Tolvaptan (drug) — also listed as: SAMSCA
placebo (drug)

Where the study takes place — 1 listed sites

Konkuk University Medical Center
Seoul, Seoul, South Korea
Site recruitment: Not reported

Original record, eligibility, contacts and results →